Influence of site classification on cancer incidence rates: An analysis of gastric cardia carcinomas

Journal of the National Cancer Institute

Volumn 96, Issue 18, 2004, Pages 1383-1387

  Corley, Douglas A ^a,b   Kubo, Ai ^c  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CARDIA; CAUCASIAN; CONTROLLED STUDY; HUMAN; INFORMATION PROCESSING; LOWER ESOPHAGUS SPHINCTER; MALE; NEGRO; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA; STOMACH FUNDUS; ADULT; AGED; CLASSIFICATION; FEMALE; INCIDENCE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STATISTICS; STOMACH TUMOR; UNITED STATES;

ADULT; AGED; CARDIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SEER PROGRAM; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; UNITED STATES;

EID: 4644226165     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh265     Document Type: Article

References (15)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
2. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update [letter]. JAMA 1993;270:1320.
3. The Web of Science. Available at: http://isiwebofknowledge.com. [Last accessed: July 29, 2004.]
4. Lagergren J, Bergstrom R, Adami HO, Nyren O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med 2000;133:165-75.
5. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
6. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83: 2049-53.
7. Kubo A, Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 2002;95: 2096-102.
8. Ekstrom AM, Signorello LB, Hansson LE, Bergstrom R, Lindgren A, Nyren O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 1999;91:786-90.
9. Faulty estimates led NCI to overstate black-white cancer disparity in Atlanta. The Cancer Letter 2002 Vol 28, Sep 20. Available at: http://www.cancerletter.com. [Last accessed: August 9, 2004.]
10. Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L, et al. SEER cancer statistics review, 1973-1997. Bethesda (MD): National Cancer Institute; 2000.
11. Percy C, Van Holten V, Muir C. International classification of diseases for oncology. 2nd ed. Geneva (Switzerland): World Health Organization; 1990.
12. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research, volume IV: descriptive epidemiology. Lyon (France): International Agency for Research on Cancer; 1994.
13. Bishop Y, Finberg S, Holland P. Discrete multivariate analysis: theory and practice. Cambridge (MA): MIT Press; 1975.
14. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999;26(5 Suppl 15):2-8.
15. Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol 1994;21:403-10.